There is no cure for the rare disease Hereditary Spastic Paraplegia (HSP), but researchers from Drexel University’s College ...

There is no cure for the rare disease Hereditary Spastic Paraplegia (HSP), but researchers from Drexel University's College ...

Texas Sen. John Cornyn sounded the alarm that a biotech startup firm that has raised some $30 million to study diseases in ...

More on AI: When it comes to folding AI tools into mammograms, AI firms believe there’s even more knowledge to be gleaned ...

An in vivo chimeric antigen receptor T-cell therapy administered without lymphodepletion exhibited activity among patients with advanced multiple myeloma, according to findings presented at ASH Annual ...

While the 21st century has been bumpy, it has also ushered in monumental scientific and technological breakthroughs that have ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Link Cell Therapies ("Link"), an oncology cell therapy company, today announced its official launch from stealth with a $60 million Series A financing that was led by Johnson & Johnson, through its ...

Global CEOs and investors remain confident in the growth outlook heading into 2026, anticipating an increase in domestic and international investment, hiring and M&A activity, according to a new study ...

This year, our scientists offered new hope for treating neurodegeneration and obesity and dramatically improved the odds that ...

Biotechnology is changing fast, and CH Biotech is right in the middle of it all. We’re seeing new ways to treat diseases, ...

In a new study, scientists at the Max Planck Institute for Evolutionary Anthropology in Leipzig analyzed the impact of more ...